Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

MillerKnoll Faces Pivotal Week with Q1 Earnings Release

Robert Sasse by Robert Sasse
September 21, 2025
in Analysis, Consumer & Luxury, Earnings
0
Herman Miller Stock
0
SHARES
123
VIEWS
Share on FacebookShare on Twitter

Investors are closely monitoring MillerKnoll, Inc. as the company prepares to announce its first-quarter fiscal 2026 results this week. The upcoming earnings report, following a period of significant leadership changes and a surprisingly strong previous quarter, is viewed as a critical indicator for the furniture manufacturer’s near-term trajectory.

Leadership Transition and Strategic Appointments

A major executive reshuffle was announced on September 5th, marking a new chapter for the company. John Hoke is set to become the new Chairman of the Board of Directors, effective October 13th. He will succeed Mike Volkema, who is stepping down after a 25-year tenure in the role.

Further changes to the executive team include the appointment of Jeff Stutz as Chief Operating Officer on September 8th. Kevin Veltman has been named interim Chief Financial Officer. These strategic appointments are widely seen as positioning the company for its next phase of growth.

Quarterly Earnings and Analyst Expectations

All eyes are on the earnings release scheduled for Tuesday, September 23rd, after the market closes.

Market analysts are forecasting earnings per share (EPS) of $0.35 on revenue of $910.97 million for Q1 2026. This forecast falls within the company’s own provided guidance range of $0.32 to $0.38 per share.

These projections come on the heels of an impressive Q4 2025 performance, where MillerKnoll reported an adjusted EPS of $0.60. This figure substantially outperformed consensus expectations of $0.44. Quarterly revenue also saw a significant year-over-year increase of 8.2%, reaching $961.8 million.

Should investors sell immediately? Or is it worth buying Herman Miller?

Share Performance and Dividend Yield

The stock presents a mixed performance picture. As of the close on Friday, September 19th, shares were trading at $20.03, down $0.41 for the day. Recent pressure followed disappointing results from sector competitor RH.

However, taking a broader view reveals notable gains; the stock has advanced an impressive 21% over the past three months, though it remains down approximately 9% for the year to date.

Shareholders are set to receive a quarterly dividend of $0.1875 per share on October 15th. On an annualized basis, this payout represents an attractive dividend yield of 3.7%.

  • Q1 Earnings Date: September 23rd (after market close)
  • Dividend: $0.1875 per share (Payable October 15th)
  • New Leadership: John Hoke (Chairman), Jeff Stutz (COO)
  • Current Share Price: $20.03 (as of September 19)
  • Institutional Ownership: 95.32%

Strong Institutional Backing

A commanding 95.32% of the company’s shares are held by institutional investors, signaling strong confidence from major financial players. Recent regulatory filings show significant activity within this group.

Jane Street Group LLC dramatically increased its stake by 311.8% during the first quarter. Similarly, the Public Sector Pension Investment Board raised its holdings by 6.9% in the second quarter. Prominent investment firms such as BlackRock, Vanguard, and AllianceBernstein count themselves among the largest shareholders. The market now watches to see how these institutions will respond to the upcoming earnings announcement.

Ad

Herman Miller Stock: Buy or Sell?! New Herman Miller Analysis from February 7 delivers the answer:

The latest Herman Miller figures speak for themselves: Urgent action needed for Herman Miller investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Herman Miller: Buy or sell? Read more here...

Tags: Herman Miller
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Graftech Stock
Commodities

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Next Post
Lufax Holding Stock

Lufax Shares Gain Momentum Ahead of Quarterly Earnings Release

Diversified Healthcare Trust Stock

Debt Reduction Strategy Yields Mixed Results for Diversified Healthcare Trust

SM Energy Stock

Is SM Energy Stock a Value Opportunity or a Value Trap?

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com